Medtech Insight is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
New GSK venture fund Action Potential joins in SetPoint Medical’s $27mm Series C; adds $15mm
12 Sep 2017
Several corporate investors--Boston Scientific, Covidien Ventures, and GlaxoSmithKline’s Action Potential Venture Capital (APVC) fund--have joined existing shareholders Morgenthaler Venture Partners, Foundation Medical Partners, and Topspin Partners in a $27mm Series C financing for SetPoint Medical Corp. (vagus nerve stimulation to prompt the body’s natural defense mechanisms against many types of chronic inflammation).
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?